Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > New Press Release - Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders

<< Previous

Bullboard Posts

Next >>

Comment by Buckhenryon May 16, 2024 3:35pm

108 Views

Post# 36044104

RE:RE:RE:RE:RE:RE:New Press Release - Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders

You pumpers are like a stuck needle on a record player. Or maybe you are the record... lots of scratches... face reality... this stock may or may not do anything. It's a craps shoot here. But continually having a pie in sky attitude is not healthy..
You have be going through a ton of sleeping and anxiety pills. Best wishes.

<< Previous

Bullboard Posts

Next >>

@ the Bell: TSX advances to start off Christmas trading week